Literature DB >> 16235673

Serial diffusion-weighted magnetic resonance imaging in cases of glioma: distinguishing tumor recurrence from postresection injury.

Justin S Smith1, Soonmee Cha, Mary Catherine Mayo, Michael W McDermott, Andrew T Parsa, Susan M Chang, William P Dillon, Mitchel S Berger.   

Abstract

OBJECT: Diffusion-weighted magnetic resonance (MR) imaging is an invaluable tool in the diagnosis of acute stroke and other types of brain injury. Abnormalities in and around the resection cavity on diffusion-weighted imaging have been observed following surgery for infiltrating glioma. The purpose of this study was to investigate prospectively the incidence, time course, and ultimate outcome of these abnormalities.
METHODS: Forty-four consecutive patients with newly diagnosed gliomas were prospectively observed using serial MR imaging including diffusion-weighted sequences. Clinical and surgical data were also collected. Immediately postoperatively neuroimaging identified 28 patients (64%) in whom areas of reduced diffusion appeared in or around the resection cavity (mean volume 8.2 +/- 1.5 cm3). Complete resolution of this reduced diffusion was demonstrated within 90 days in 24 patients (86%). On subsequent neuroimages these areas demonstrated Gd enhancement as early as postoperative Day 15 and as late as Day 198 and ultimately took on the appearance of encephalomalacia in 26 (93%) of 28 cases. Postoperative reduced diffusion was not predicted by the clinical or surgical parameters that were assessed. No clinical deficits were attributable to the reduced diffusion.
CONCLUSIONS: An abnormality related to diffusion-weighted sequences on postoperative MR imaging can occur after resection of newly diagnosed gliomas. In this study the abnormality typically resolved and was replaced by contrast enhancement on follow-up imaging, ultimately demonstrating encephalomalacia on long-term follow up. Findings on neuroimaging during the period of enhancement could be confused with recurrent tumor and interpreted as early treatment failure. Based on the findings of this study the authors strongly suggest that the inclusion of diffusion-weighted sequences in postoperative MR imaging is essential, as is MR imaging immediately before radiation therapy to monitor disease progression. A new enhancement observed after glioma surgery should be interpreted in the context of the diffusion-weighted image obtained immediately postoperatively.

Entities:  

Mesh:

Year:  2005        PMID: 16235673     DOI: 10.3171/jns.2005.103.3.0428

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  53 in total

Review 1.  Multimodality Brain Tumor Imaging: MR Imaging, PET, and PET/MR Imaging.

Authors:  James R Fink; Mark Muzi; Melinda Peck; Kenneth A Krohn
Journal:  J Nucl Med       Date:  2015-08-20       Impact factor: 10.057

Review 2.  Update on brain tumor imaging: from anatomy to physiology.

Authors:  S Cha
Journal:  AJNR Am J Neuroradiol       Date:  2006-03       Impact factor: 3.825

Review 3.  Diffusion tensor MR imaging and fiber tractography: theoretic underpinnings.

Authors:  P Mukherjee; J I Berman; S W Chung; C P Hess; R G Henry
Journal:  AJNR Am J Neuroradiol       Date:  2008-03-13       Impact factor: 3.825

Review 4.  Brain tumor imaging in clinical trials.

Authors:  J W Henson; S Ulmer; G J Harris
Journal:  AJNR Am J Neuroradiol       Date:  2008-02-13       Impact factor: 3.825

5.  Tumor regrowth between surgery and initiation of adjuvant therapy in patients with newly diagnosed glioblastoma.

Authors:  Andrea Pirzkall; Colleen McGue; Suja Saraswathy; Soonmee Cha; Raymond Liu; Scott Vandenberg; Kathleen R Lamborn; Mitchel S Berger; Susan M Chang; Sarah J Nelson
Journal:  Neuro Oncol       Date:  2009-12       Impact factor: 12.300

Review 6.  Neuroimaging in neuro-oncology.

Authors:  Soonmee Cha
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

7.  Haemostatic material (Surgicel®) mimicking residual tumour: magnetic resonance imaging findings in operated pediatric neuro-oncology cases.

Authors:  Serena Staglianò; Felice D'Arco; Ai Peng Tan; Owase Jeelani; Giovanni Morana; Kshitij Mankad
Journal:  Quant Imaging Med Surg       Date:  2018-10

8.  Prognostic paradox: brain damage around the glioblastoma resection cavity.

Authors:  Takuya Furuta; Mitsutoshi Nakada; Fumiaki Ueda; Takuya Watanabe; Yasuaki Arakawa; Ryo Higashi; Masaaki Hashimoto; Hisashi Nitta; Yutaka Hayashi; Jun-ichiro Hamada
Journal:  J Neurooncol       Date:  2014-03-07       Impact factor: 4.130

9.  Comparison of intraoperative and post-operative 3-T MRI performed at 24-72 h following brain tumour resection in children.

Authors:  Shivaram Avula; Tim Jaspan; Barry Pizer; Benedetta Pettorini; Deborah Garlick; Dawn Hennigan; Conor Mallucci
Journal:  Neuroradiology       Date:  2021-02-25       Impact factor: 2.804

10.  Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy.

Authors:  Suja Saraswathy; Forrest W Crawford; Kathleen R Lamborn; Andrea Pirzkall; Susan Chang; Soonmee Cha; Sarah J Nelson
Journal:  J Neurooncol       Date:  2008-09-23       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.